Human Milk Oligosaccharides Market Size Is Expected To Reach USD 688.5 Million By 2030

 San Francisco, 5 April 2024: The Report Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Type (2’FL, 3’FL, 3’SL, 6’SL, LNT, LNnT), By Application (Food & Beverages, Dietary Supplements, Infant Formula, Pharmaceuticals), By Region, And Segment Forecasts, 2024 - 2030

The global human milk oligosaccharides market size is expected to reach USD 688.5 million by 2030, expanding at a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for human milk oligosaccharides (HMOs) is being driven by several key factors. Firstly, there is a growing awareness among consumers about the health benefits of HMOs. Human milk is known to contain a complex mixture of bioactive compounds, and HMOs are one of the most abundant components. HMOs play a crucial role in supporting the development of a healthy immune system, promoting the growth of beneficial gut bacteria, and reducing the risk of certain diseases.

Secondly, there is an increasing demand for HMOs in the infant formula industry. As breastfeeding rates decline and more infants are fed with formula, manufacturers are seeking to bridge the nutritional gap between breast milk and formula. HMOs are being recognized as valuable additions to infant formula, as they can help mimic the benefits of human milk and provide a more complete nutritional profile for infants.

Furthermore, the market for HMOs is also being driven by advancements in biotechnology and production techniques. Traditionally, HMOs were extracted from human breast milk, which limited their availability and made them expensive. However, researchers have developed innovative methods to produce HMOs through microbial fermentation, making them more accessible and cost-effective. This has opened up new opportunities for HMO production and expanded their potential applications.

In May 2022, Nestlé China launched three new infant formulas containing human milk oligosaccharides (HMOs) for newborns with allergies to cow milk protein. The products are available via cross-border e-commerce as China does not allow HMOs in infant formula.

Access Research Report of Human Milk Oligosaccharides Market @ https://www.grandviewresearch.com/industry-analysis/human-milk-oligosaccharides-market

Human Milk Oligosaccharides Market Report Highlights

• 2’FL dominated the product type segment with a revenue share of over 36.9% in 2023 owing to the growing demand for infant formula that contains HMOs, particularly in regions where breastfeeding rates are low.
• The infant formula was the dominant application in the global market, making up 75.6% of the total revenue in 2023. HMOs in infant formulas are in high demand for their benefits: gut health, memory enhancement, brain development, infection prevention, and prebiotic effects.
• Some of the key players in the market include Chr. Hansen Holding A/S, Kyowa Hakko Europe GmbH, ZuChem Inc., Elicityl SA, FrieslandCampina Ingredients, Inbois N.V. and Carbosynth Limited.

Human Milk Oligosaccharides Market Report Scope

Report Attribute	Details
The market size value in 2024	USD 298.6 million
The revenue forecast in 2030	USD 688.5 million
Growth Rate	CAGR of 14.9% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

List of Key Players in the Human Milk Oligosaccharides Market

• Hansen Holding A/S
• Kyowa Hakko Europe GmbH
• ZuChem Inc.
• Elicityl SA
• FrieslandCampina Ingredients
• Inboise N.V.
• Glycom A/S
• DSM
• Dextra Laboratories Limited
• Carbosynth Limited
• RAJVI ENTERPRISE

Access Press Release of Human Milk Oligosaccharides Market @ https://www.grandviewresearch.com/press-release/global-human-milk-oligosaccharides-market